Skip to main content
Top
Published in:

Open Access 01-11-2024 | Research

What individual needs do family caregivers have in palliative home care and how are they supported? A qualitative study of a supportive intervention

Authors: Christiane Kreyer, Barbara Stecher, Sabine Pleschberger, Gail Ewing

Published in: Supportive Care in Cancer | Issue 11/2024

Login to get access

Abstract

Purpose

Family caregivers (FCGs) play a pivotal role in supporting patients in palliative care at home. Person-centred support is crucial to prevent negative outcomes; therefore, evidence-based approaches such as the Carer Support Needs Assessment Tool Intervention (CSNAT-I) are promising. To understand more about the delivery of the intervention, the study focuses on documentation of CSNAT-I in practice in Austria to identify which support needs were discussed with the FCGs and the types of support delivered to meet these needs.

Methods

A retrospective analysis of electronic records was conducted, focusing on documented entries related to the delivery of CSNAT-I over a 21-month period (Dec 2019 to Aug 2021). Both qualitative and quantitative methods were employed for data analysis.

Results

The analysis identified a wide spectrum of FCG support needs, categorised into enabling domains related to caregiving for the patient and direct support needs concerning FCGs’ own health and well-being. The most frequently documented support needs included ‘having time for oneself in the day’ and ‘dealing with feelings and worries’, highlighting the challenges FCGs face in balancing caregiving responsibilities with personal life. Supportive input encompassed advice and information, counselling, education and training, coordination and arrangement, and signposting and referral.

Conclusion

The study stresses the importance of addressing both practical and psychosocial aspects of caregiving, utilising a person-centred approach. Nurses provided comprehensive support mostly directly delivered during their contact with FCGs. CSNAT-I demonstrated flexibility, accommodating the diverse needs of FCGs in different situations, and may contribute to a more supportive care environment.
Literature
10.
go back to reference Payne S, Hudson PL, Grande G et al (2010) EAPC White Paper on improving support for family carers in palliative care: part 1. Eur J Palliat Care 17(5):238–245 Payne S, Hudson PL, Grande G et al (2010) EAPC White Paper on improving support for family carers in palliative care: part 1. Eur J Palliat Care 17(5):238–245
26.
go back to reference Lund L, Ross L, Petersen MA et al (2022) Process, content, and experiences of delivering the Carer Support Needs Assessment Tool Intervention (CSNAT-I) in the Danish specialised palliative care setting. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 30(1):377–387. https://doi.org/10.1007/s00520-021-06432-1CrossRef Lund L, Ross L, Petersen MA et al (2022) Process, content, and experiences of delivering the Carer Support Needs Assessment Tool Intervention (CSNAT-I) in the Danish specialised palliative care setting. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 30(1):377–387. https://​doi.​org/​10.​1007/​s00520-021-06432-1CrossRef
Metadata
Title
What individual needs do family caregivers have in palliative home care and how are they supported? A qualitative study of a supportive intervention
Authors
Christiane Kreyer
Barbara Stecher
Sabine Pleschberger
Gail Ewing
Publication date
01-11-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08904-6

Other articles of this Issue 11/2024

Supportive Care in Cancer 11/2024 Go to the issue
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version